$KMPH So look, for the newbies, just a few points. 1) Without a reverse split, there's no debt rollover. Without debt rollover, KemPharm goes bankrupt when the debt is due. Perhaps the better choice, in retrospect. 2) From my point of view, it seems really dumb to do an offering before approval -- before KemPharm gets a commitment from GPC for the $48m --, and obviously the stock price reflects this. I want to believe that Deerfield forced this structure on KemPharm. 3) It boils down to the truth that KemPharm could not get any other parties to buy the ever-increasing debt. We were hopeful, but it didn't happen.